Visual and Refractive Outcomes Following Stream Light Photorefractive Keratectomy (55μm Epithelial Removal) Versus Conventional Photorefractive Keratectomy
NCT ID: NCT07203976
Last Updated: 2025-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
100 participants
OBSERVATIONAL
2025-05-03
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Trans-epithelial PRK (StreamLight) performed on the EX500 excimer laser platform removes the epithelium and reshapes the corneal stroma in a single laser-guided step, potentially reducing tissue manipulation and enhancing epithelial healing. In contrast, manual epithelial removal PRK involves mechanical debridement, with epithelial removal depth being manually controlled. The variability of epithelial thickness in StreamLight PRK may influence visual outcomes, whereas in manual PRK, a fixed epithelial removal depth of 55 microns provides a standardized approach.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Outcomes of a New Trans-epithelial Photorefractive Keratectomy (Streamlight PRK) Compared to Conventional PRK Procedures
NCT04710082
Photorefractive Keratectomy for Severe Anisometropia and Isoametropia Associated With Amblyopia
NCT03610997
Single-step Transepithelial PRK for Hyperopia
NCT05261685
A Comparative Study Between Laser and Manual Removal of Corneal Epithelium for Photorefractive Keratectomy
NCT06748599
Dry Eye Evaluation After Transepithelial PRK
NCT02210793
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Type of the study: Retrospective cross-sectional study
* Study Setting: Alforsan Eye Centre
* Study subjects:
a. Inclusion criteria:
* Patients aged 18-40 years.
* Myopia up to -6.00 D and astigmatism up to -3.00 D.
* Stable refraction for at least one year.
* No history of ocular surgery or corneal pathology. b. Exclusion criteria:
* Presence of keratoconus or suspected corneal ectasia.
* Severe dry eye disease or significant ocular surface disease.
* History of autoimmune disease or systemic conditions affecting wound healing.
* Prior herpetic eye disease. c. Sample Size Calculation: A sample size calculation will be performed to ensure adequate statistical power. Anticipated enrollment: \[e.g., 50 eyes per group\] based on previous PRK outcome studies (Marshall et al., 2018).
* Study tools (in detail, e.g., lab methods, instruments,steps, chemicals, …):
* Alcon Wavelight EX500 excimer laser (Alcon Laboratories, Fort Worth, TX, USA)
* Wavelight Oculyzer II Am Wolfsmantel 5, Erlangen, Germany
* Autorefractor KR-8900 (Topcon, Tokyo, Japan)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients aged 18-40 years, myopia up to -6.00 D and astigmatism up to -3.00 D and Stable refraction
The visual and refractive outcomes of Stream Light Photorefractive keratectomy with fixed epithelial removal.
No interventions assigned to this group
Patients aged 18-40 years, myopia up to -6.00 D and astigmatism up to -3.00 D and Stable refraction
The visual and refractive outcomes of manual Photorefractive keratectomy with fixed epithelial removal.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Myopia up to -6.00 D and astigmatism up to -3.00 D.
* Stable refraction for at least one year.
* No history of ocular surgery or corneal pathology.
Exclusion Criteria
* Severe dry eye disease or significant ocular surface disease.
* History of autoimmune disease or systemic conditions affecting wound healing.
* Prior herpetic eye disease.
18 Years
40 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assiut University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Menatallah Gamal Saleh
lecturer of ophthalmology
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of medicine, Assiut
Asyut, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
3. Marshall, J., Trokel, S. L., Rothery, S., & Krueger, R. R. (2018). Refractive corneal surgery: The role of epithelial healing and biomechanics. Cornea, 37(7), 853-860.
Fantes FE, Hanna KD, Waring GO 3rd, Pouliquen Y, Thompson KP, Savoldelli M. Wound healing after excimer laser keratomileusis (photorefractive keratectomy) in monkeys. Arch Ophthalmol. 1990 May;108(5):665-75. doi: 10.1001/archopht.1990.01070070051034.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
04-2025-300627
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.